Economic aspects of different muscle relaxant regimens

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 35, Issue 5, 2000, Pages 300-305

  Suttner, S ^a   Boldt, Joachim ^a   Piper, S N ^a   Schmidt, C ^a   Kumle, B ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Costs; Muscle relaxants; Pharmacoeconomics

Indexed keywords

ANESTHETIC AGENT; ATRACURIUM; ATROPINE; CISATRACURIUM; DESFLURANE; FENTANYL; LORAZEPAM; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; ROCURONIUM; THIOPENTAL; VECURONIUM;

ADULT; AGED; ARTICLE; CHOLECYSTECTOMY; DRUG COST; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; SURGICAL PATIENT;

ADULT; AGED; AGED, 80 AND OVER; ANDROSTANOLS; ANESTHESIA; ATRACURIUM; CHOLECYSTECTOMY, LAPAROSCOPIC; DRUG COSTS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VECURONIUM BROMIDE;

EID: 0034043071     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-325     Document Type: Article

References (23)

1. Vitez TS: Principles of cost analysis. J Clin Anesth 1994; 6: 357-363
2. Watcha MF: Economics of anesthetic practice. Anesthesiology 1997; 86: 1170-1196
3. Sperry RJ: Principles of economic analysis. Anesthesiology 1997; 86: 1197-1205
4. Broadway PJ, Jones JG: A method of costing anaesthetic practice. Anaesthesia 1995; 50: 56-63
5. Kapur PA: Pharmacy acquisition costs: responsible choices versus over utilization of costly pharmaceuticals. Anesth Analg 1994; 78: 617-618
6. Johnstone RE, Jozefcyk KG: Cost of anesthetic drugs: experience with a cost education trial. Anesth Analg 1994; 78: 766-771
7. Lubarsky DA, Glass PSA, Ginsberg B, Ginsberg B, de L Dear G, Dentz ME, Gan TJ, Sanderson IC, Mythen MG, Dufore S, Pressley CG, Gilbert WC, White WD, Alexander ML, Coleman RL, Rogers M, Reves JG: The successful implementation of pharmaceutical practice guidelines. Anesthesiology 1997; 86: 1145-1160
8. Freund PR, Bowdle TA, Posner KL, Kharasch ED, Burkhart VD: Cost-effective reduction of neuromuscular blocking drugs expenditures. Anesthesiology 1997; 87: 1044-1049
9. Lien CA, Schmith VD, Belmont MR, Abalos A, Kisor DF, Savarese JJ: Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1996; 84: 300-308
10. Booth MG, Marsh B, Bryden FMM, Robertson EN, Baird WLM: A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia. Anaesthesia 1992; 47: 832-843
11. DeMonaco HJ, Shah AS: Economic considerations in the use of neuromuscular blocking drugs. J Clin Anesth 1994; 6: 383-387
12. Szocik JF, Learned DW: Impact of a cost containment program on the use of volatile anesthetics and neuromuscular blocking drugs. J Clin Anesth 1994; 6: 378-382
13. Aldrete JA, Kroulik D: A postanesthetic recovery score. Anesth Analg 1970; 49: 924-933
14. Weiskopf RB, Eger EI: Comparing the cost of inhaled anesthetics. Anesthesiology 1993; 79: 1413-1418
15. Boldt J, Jaun N, Kumle B, Heck M, Mund K: Economic considerations of the use of new anesthetics: a comparison of propofol, sevoflurane, desflurane, and isoflurane. Anesth Analg 1998; 86: 504-509
16. Johans TG: The cost of propofol. Anesth Analg 1995; 80: 1252-1253
17. Bryson HM, Faulds D: Cisatracurium besilate: A review of its pharmacology and clinical potential in anesthetic practice. Drugs 1997; 53: 848-866
18. Cooper JO: The relative costs of anesthesia drugs in New Zealand versus the United States. Anesth Analg 1995; 80: 848-857
19. Becker KE, Carrithers J: Practical methods of cost containment in anesthesia and surgery. J Clin Anesth 1994: 6: 388-399
20. Ballantyne JC, Chang Y: The impact of choice of muscle relaxant on postoperative recovery time: a retrospectiv study. Anesth Analg 1997; 85: 476-482
21. Berg H, Viby-Mogensen J, Roed J, Engbaek J, Skovgaard LT, Krintel JJ: Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised and blinded study of postoperative pulmonary complications after atracurium, vecuronium, and pancuronium. Acta Anaesthesiol Scand 1997; 41: 1095-1103
22. Caldwell JE: The problem with long-acting muscle relaxants? They cost more. Anesth Analg 1997; 85: 473-475
23. Searle NR, Sahab P, Blain R, Taillefer J, Hardy JF, Roy M, Gagnon L, Belisle S: Hemodynamic and pharmacodynamic comparison of doxacurium and high-dose vecuronium during coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1994; 8: 490-494